Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionEris Lifesciences’ insatiable appetite for growth is driving up its debt

    Eris Lifesciences’ insatiable appetite for growth is driving up its debt

    After Biocon Biologics' formulation deal, net debt at the company is estimated to rise from Rs 886 crore to Rs 2,400 crore

    R. Sree Ram
    March 15, 2024 / 10:19 IST
    The acquisition will increase debt of Eris Lifesciences
    • PRO Panorama

      Moneycontrol Pro Panorama | Is India an AI hedge trade?

      Nov 10, 2025 / 02:56 PM IST

      In November 10 edition of Moneycontrol Pro Panorama: RBI opens M&A loan gate are Indian banks ready, extended US shutdown clouds m...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts